Scientists test new Drug's brain effects using ketamine
NCT ID NCT03844906
Summary
This early-stage study tested an investigational drug called SAGE-718 in 40 healthy volunteers. Researchers used ketamine to temporarily alter brain activity and measured whether SAGE-718 could affect these changes. The main goals were to check the drug's safety, how the body processes it, and its impact on brain wave patterns.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sage Investigational Site
Long Beach, California, 90806, United States
-
Sage Investigational Site
Berlin, New Jersey, 08009, United States
Conditions
Explore the condition pages connected to this study.